Given the role of Nrf2 signaling in chemotherapeutic resistance and CSC survival21,22, we first explored the expression of several prominent CSC markers in HNSCC using 513 cases from TCGA dataset. The gene discussed is NFE2L2; the disease is head and neck squamous cell carcinoma.